Amer M Zeidan

38PUBLICATIONS
188CO-AUTHORS
Gene and molecular therapyBiomolecular modelling and designMedical mycologyRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Jun 17, 2026
Beyond the Catalogue: Design and Biological Enrichment as the Next Priorities in Higher-Risk MDS Drug Development.

|Apr 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

|Apr 25, 2026
Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.

|Apr 14, 2026
A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions.

Jan Philipp Bewersdorf, Alain Mina, Maximilian Stahl

|Apr 07, 2026
Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes.

Amer M Zeidan, Valeria Santini, María Díez-Campelo

Pageof 7

Frequent Collaborators

7 joint publications

Rami S Komrokji

7 joint publications

Jan Philipp Bewersdorf

6 joint publications

Valeria Santini

5 joint publications

Guillermo Garcia-Manero